top of page
검색

VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal

  • 작성자 사진: nuaxia
    nuaxia
  • 1일 전
  • 2분 분량

The agreement adds advanced imaging capabilities to the xvision Spine System platform, supporting broader adoption of augmented reality navigation in spinal procedures.


US-based medical technology company VB Spine has signed an agreement with Augmedics to acquire exclusive rights to its computed tomography-to-fluoroscopy (CT-Fluoro) technology for spinal applications.

The transaction builds on VB Spine’s earlier acquisition of exclusive rights to the Augmedics xvision Spine System, further expanding its portfolio of image-guided surgical technologies.

Financial terms of the agreement were not disclosed, with completion subject to customary closing conditions and regulatory approvals.

Reducing Barriers to Spine Navigation

Augmedics’ CT-Fluoro technology is designed to allow surgeons to register a patient’s preoperative CT scan using standard fluoroscopic imaging during spinal procedures.

By reducing dependence on intraoperative CT or advanced 3D imaging systems, the technology could provide hospitals and surgical centres with greater flexibility when implementing navigation workflows.

VB Spine believes the platform could help make augmented reality (AR)-based spine navigation more accessible across a wider range of healthcare settings.

Building on the xvision Spine System

The acquisition complements VB Spine’s existing focus on the xvision Spine System, an augmented reality navigation platform designed to provide surgeons with real-time guidance during spinal procedures.

The system uses AR technology to display surgical navigation information directly within the surgeon’s field of view, helping support implant placement and procedural accuracy.

VB Spine said integrating CT-Fluoro capabilities into its portfolio will provide surgeons with additional options for how navigation technology is used during operations.

Supporting Technology-Enabled Spine Care

VB Spine co-CEO Marc Viscogliosi said the company’s goal is to remove barriers that limit access to technologies designed to improve surgical efficiency and patient care.

The addition of CT-Fluoro technology is expected to strengthen the xvision platform by expanding workflow flexibility for surgeons and healthcare facilities.

Following completion of the deal, VB Spine plans to make the technology available as part of its broader spine procedure portfolio.

Expanding Medical Technology Footprint

The agreement represents another step in VB Spine’s strategy to develop a broader ecosystem of digital and image-guided solutions for spinal surgery.

Earlier in 2026, the company agreed to acquire the SpineHawk intraoperative spinal visualisation platform from Robotron Surgical Technologies.

That acquisition was aimed at expanding VB Spine’s capabilities in intraoperative imaging and advancing a software-focused roadmap for technology-enabled spine care.

Why the Deal Matters

The partnership reflects several wider trends in surgical technology:

  • Augmented reality navigation is becoming increasingly important in complex procedures.

  • Medical device companies are combining imaging, software and navigation technologies to improve surgical workflows.

  • Reducing reliance on expensive imaging infrastructure could increase access to advanced surgical tools.

  • Spine surgery continues to be a major focus area for digital health and medtech innovation.

Summary

VB Spine has agreed to acquire exclusive rights to Augmedics’ CT-Fluoro technology for spine applications, expanding its augmented reality navigation capabilities.

The deal strengthens the xvision Spine System platform and supports VB Spine’s broader ambition to improve access to advanced image-guided technologies across spinal surgery.

Discover how nuaxia can support your next medical education initiative:

 
 
 

댓글

별점 5점 중 0점을 주었습니다.
등록된 평점 없음
평점 추가
bottom of page